Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines: Multi-center, Single Arm, Open, Extension Study

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03184363

Enrollment

102

Registered

2017-06-12

Start date

2017-07-31

Completion date

2017-12-31

Last updated

2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crow's Feet Lines, Glabellar Lines

Brief summary

The purpose of this study is to explore the Efficacy and Safety of DWP450 for treating Crows Feet Lines(CFL) in combination with glabellar line(GL) as extension study of phase 3 study for CFL.

Interventions

DRUGClostridium Botulinum A Toxin

Clostridium Botulinum A Toxin

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Male or female of at least 18 to 75 years old * moderate-to-severe CFL at maximum smile on the FWS as rated by the investigator * moderate-to-severe GL at maximum frawn on the FWS as rated by the investigator * Subject who has completed phase 3 study for CFL.

Design outcomes

Primary

Measure	Time frame	Description
Subject Assessment of Satisfaction of Appearance	At 4 weeks	Subject Assessment of Satisfaction of Appearance

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026